European Radiology

, Volume 16, Issue 7, pp 1580–1590 | Cite as

Contemporary issues in the diagnosis of prostate cancer for the radiologist



Prostate cancer diagnostic techniques have improved considerably in recent years, but they must yet be optimised to ensure cancer detection at a potentially curable stage. Arrangements for prostate biopsy vary throughout Europe, and prostate biopsy may be undertaken by urologists or radiologists. This review discusses current issues relevant for radiologists involved in the detection of early prostate cancer. Prostate biopsy should be based on a systematic approach involving 8–12 cores obtained with peri-prostatic infiltration of local anaesthetic. Quality issues being considered by the United Kingdom Prostate Cancer Risk Management Programme are discussed.


Prostate cancer Biopsy Diagnosis 


  1. 1.
    Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, Spangberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, Norlen BJ, Johansson JE (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1977–1984CrossRefPubMedGoogle Scholar
  2. 2.
    Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ (2004) Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3:478 consecutive patients: long-term results. J Urol 172:910–914CrossRefPubMedGoogle Scholar
  3. 3.
    Albertsen PC, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293:2095–2101CrossRefPubMedGoogle Scholar
  4. 4.
    Gray JM (2005) Population screening and patient testing using PSA. BJU Int 95 [Suppl 3]:iGoogle Scholar
  5. 5.
    Wilson JMG, Junger G (1968) Principles and practice of screening for disease. World Health Organisation, GenevaGoogle Scholar
  6. 6.
    Shah JB, Reese AC, McKiernan JM, Benson MC (2005) PSA updated: still relevant in the new millennium? Eur Urol 47:427–432CrossRefPubMedGoogle Scholar
  7. 7.
    Andriole GL, Catalona WJ (1993) Using PSA to screen for prostate cancer. The Washington University experience. Urol Clin North Am 20:647–651PubMedGoogle Scholar
  8. 8.
    Schroder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R (2000) Prostate cancer detection at low prostate specific antigen. J Urol 163:806–812CrossRefPubMedGoogle Scholar
  9. 9.
    Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA Jr (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level <or=4.0 ng per milliliter. N Engl J Med 350:2239–2246CrossRefPubMedGoogle Scholar
  10. 10.
    Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, Rimmer J, Sturgeon C, White P, Allen NE (2005) Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2–10 ng/ml: systematic review and meta-analysis. Eur Urol 48:386–399CrossRefPubMedGoogle Scholar
  11. 11.
    Stamey T, Caldwell M, McNeal J, Nolley R, Hemenez M, Downs J (2004) The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 172:1297–1301CrossRefPubMedGoogle Scholar
  12. 12.
    American Urological Association American Urological Association AU (2000) Prostate-specific antigen (PSA) best practice policy. Oncology (Huntingt) 14:267–272Google Scholar
  13. 13.
    Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH (1992) Prostate specific antigen density: a means of distinguishing benign prostatic hyperplasia and prostate cancer. J Urol 147:815–816PubMedGoogle Scholar
  14. 14.
    Winkler MH, Kulinskaya E, Gillatt DA (2004) Prediction of prostate cancer in extended-field biopsies of the prostate. BJU Int 93:516–521CrossRefPubMedGoogle Scholar
  15. 15.
    Carter HB, Pearson JD, Metter J, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267:2215–2220CrossRefPubMedGoogle Scholar
  16. 16.
    Brawer MK, Beatie J, Wener MH, Vessella RL, Preston SD, Lange PH (1993) Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J Urol 150:106–109PubMedGoogle Scholar
  17. 17.
    Wilson SS, Crawford ED (2004) Screening for prostate cancer. Urol Clin North Am 31:219–226CrossRefPubMedGoogle Scholar
  18. 18.
    D’Amico AV, Chen MH, Roehl KA, Catalona WJ (2004) Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351:125–135CrossRefPubMedGoogle Scholar
  19. 19.
    Lindert KA, Kabalin JN, Terris MK (2000) Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 164:76–80CrossRefPubMedGoogle Scholar
  20. 20.
    Carey JM, Korman HJ (2001) Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 166:82–85CrossRefPubMedGoogle Scholar
  21. 21.
    Brewster SF, Rooney N, Kabala J, Feneley RCL (1993) Fatal anaerobic infection following transrectal biopsy of a rare prostatic tumour. Br J Urol 77:977–978Google Scholar
  22. 22.
    Aron M, Rajeev TP, Gupta NP (2000) Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85:682–685CrossRefPubMedGoogle Scholar
  23. 23.
    Donzella JG, Merrick GS, Lindert DJ, Andreini HJ Jr, Curtis RL, Luna IH, Allen Z, Butler WM (2004) Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland. Urology 63:306–308CrossRefPubMedGoogle Scholar
  24. 24.
    Ihezue CU, Smart J, Dewbury KC, Mehta R, Burgess L (2005) Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol 60:459–463CrossRefPubMedGoogle Scholar
  25. 25.
    Rodriguez LV, Terris MK (1998) Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 160:2115–2120CrossRefPubMedGoogle Scholar
  26. 26.
    Connor SEJ, Wingate JP (1999) Management of patients treated with aspirin or warfarin and evaluation of haemostasis prior to prostatic biopsy ; a survey of current practice amongst radiologists and urologists. Clin Radiol 54:598–603CrossRefPubMedGoogle Scholar
  27. 27.
    Herget EJ, Saliken JC, Donnelly BJ, Gray RR, Wiseman D, Brunet G (1999) Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications. Can Assoc Radiol J 50:173–176PubMedGoogle Scholar
  28. 28.
    Clements R, Aideyan OU, Griffiths GJ, Peeling WB (1993) Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol 47:125–126PubMedCrossRefGoogle Scholar
  29. 29.
    De Sio M, D’Armiento M, Di Lorenzo G, Damiano R, Perdona S, De Placido S, Autorino R (2005) The need to reduce patient discomfort during transrectal ultrasonography-guided prostate biopsy: what do we know? BJU Int 96:977–983CrossRefPubMedGoogle Scholar
  30. 30.
    Desgrandchamps F, Meria P, Irani J, Desgrippes A, Teillac P, Le Duc A (1999) The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography-guided biopsy of the prostate: a prospective randomized placebo-controlled study. BJU Int 83:1007–1009CrossRefPubMedGoogle Scholar
  31. 31.
    Chang SS, Alberts G, Wells N, Smith JA Jr, Cookson MS (2001) Intrarectal lidocaine during transrectal prostate biopsy: results of a prospective double-blind randomized trial. J Urol 166:2178–2180CrossRefPubMedGoogle Scholar
  32. 32.
    Nash PA, Bruce JE, Indudhara R, Shinohara K (1996) Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J Urol 155:607–609CrossRefPubMedGoogle Scholar
  33. 33.
    Seymour H, Perry MJ, Lee-Elliot C, Dundas D, Patel U (2001) Pain after transrectal ultrasonography-guided prostate biopsy: the advantages of periprostatic local anaesthesia. BJU Int 88:540–544CrossRefPubMedGoogle Scholar
  34. 34.
    Schostak M, Christoph F, Muller M, Heicappell R, Goessl G, Staehler M, Miller K (2002) Optimizing local anesthesia during 10-core biopsy of the prostate. Urology 60:253–257CrossRefPubMedGoogle Scholar
  35. 35.
    Wu CL, Carter HB, Naqibuddin M, Fleisher LA (2001) Effect of local anesthetics on patient recovery after transrectal biopsy. Urology 57:925–929CrossRefPubMedGoogle Scholar
  36. 36.
    Obek C, Onal B, Ozkan B, Onder AU, Yalcin V, Solok V (2002) Is periprostatic local anesthesia for transrectal ultrasound guided prostate biopsy associated with increased infectious or hemorrhagic complications? A prospective randomized trial. J Urol 168:558–561CrossRefPubMedGoogle Scholar
  37. 37.
    Lee-Elliott CE, Dundas D, Patel U (2004) Randomized trial of lidocaine vs lidocaine/bupivacaine periprostatic injection on longitudinal pain scores after prostate biopsy. J Urol 171:247–250CrossRefPubMedGoogle Scholar
  38. 38.
    Epstein JI, Lecksell K, Carter HB (1999) Prostate cancer sampled on sextant needle biopsy: significance of cancer on multiple cores from different areas of the prostate. Urology 54:291–294CrossRefPubMedGoogle Scholar
  39. 39.
    Wise AM, Stamey TA, McNeal JE, Clayton JL (2002) Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60:264–269CrossRefPubMedGoogle Scholar
  40. 40.
    Terris MK, Wallen EM, Stamey TA (1997) Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int 59:239–242PubMedCrossRefGoogle Scholar
  41. 41.
    Liu P, Terris M, McNeal JE et al (1995) Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 153:1000–1003CrossRefPubMedGoogle Scholar
  42. 42.
    Bauer JJ, Zeng J, Weir J, Zhang W, Sesterhenn IA, Connelly RR, Moul JW (1999) 3-D computer simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer. Urology 53:961–967CrossRefPubMedGoogle Scholar
  43. 43.
    Salomon L, Colombel M, Patard JJ, Bellot J, Chopin DK, Abbou CC (1998) Use of three additional mid biopsies to improve local assessment of prostate cancer in patients with one positive sextant biopsy. Eur Urol 34:313–317CrossRefPubMedGoogle Scholar
  44. 44.
    Presti JC Jr, Chang JJ, Bhargava V, Shinohara K (2000) The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 163:163–166CrossRefPubMedGoogle Scholar
  45. 45.
    Stewart CS, Leibovich BC, Weaver AL, Lieber MM (2001) Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166:86–92CrossRefPubMedGoogle Scholar
  46. 46.
    Bott SR, Young MP, Kellett MJ, Parkinson MC (2002) Anterior prostate cancer: is it more difficult to diagnose? BJU Int 89:886–889CrossRefPubMedGoogle Scholar
  47. 47.
    Brossner C, Madersbacher S, Klinger HC, Pycha A, Kuber W, Marberger M (1998) A comparative study of a double-line versus a fan-shaped technique for obtaining transrectal ultrasound-guided biopsies of the prostate. Eur Urol 33:556–561CrossRefPubMedGoogle Scholar
  48. 48.
    Kleinjen J, Eichler K (2005) Diagnostic value of systematic prostate biopsy methods in the investigations for prostate cancer: a systematic review. In: Centre for Reviews & Dissemination. University of YorkGoogle Scholar
  49. 49.
    Brnic Z, Gasparov S, Lozo PV, Anic P, Patrlj L, Ramljak V (2005) Is quadrant biopsy sufficient in men likely to have advanced prostate cancer? Comparison with extended biopsy. Pathol Oncol Res 11:40–44PubMedCrossRefGoogle Scholar
  50. 50.
    McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988) Zonal distribution of prostatic adenocarcinoma. Am J Surg Pathol 12:897–906PubMedCrossRefGoogle Scholar
  51. 51.
    Djavan B, Remzi M, Schulman C, Marberger M, Zlotta A (2002) Repeat prostate biopsy: who, how and when? A review. Eur Urol 42:93–103CrossRefPubMedGoogle Scholar
  52. 52.
    Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr (1995) The influence of prostate size on cancer detection. Urology 46:831–836CrossRefPubMedGoogle Scholar
  53. 53.
    Mariappan P, Chong WL, Sundram M, Mohamed SR (2004) Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity. BJU Int 94:307–310CrossRefPubMedGoogle Scholar
  54. 54.
    Vanasupa B, Miller T, Schwartz B (2000) Diagnosis of prostate adenocarcinoma using transurethral resection of the prostate after multiple negative transrectal biopsies and persistently elevated prostate-specific antigen level. Urology 56:1056xi–1056xiiCrossRefGoogle Scholar
  55. 55.
    Griffiths GJ, Clements R, Jones DR, Roberts EE, Peeling WB, Evans KT (1987) The ultrasound appearances of prostatic cancer with histologic correlation. Clin Radiol 38:219–227CrossRefPubMedGoogle Scholar
  56. 56.
    Lee F, Torp-Pedersen S, Littrup PJ, McLeary RD, McHugh TA, Smid AP, Stella PJ, Borlaza GS (1989) Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology 170:29–32PubMedGoogle Scholar
  57. 57.
    Vilanova JC, Comet J, Capdevila A, Barcelo J, Dolz JL, Huguet M, Barcelo C, Aldoma J, Delgado E (2001) The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients. Eur Radiol 11:229–235CrossRefPubMedGoogle Scholar
  58. 58.
    Rifkin MD, Sudakoff GS, Alexander AA (1993) Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 186:509–513PubMedGoogle Scholar
  59. 59.
    Lavoipierre AM, Snow RM, Frydenberg M, Gunter D, Reisner G, Royce PL, Lavoipierre GJ (1998) Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol 171:205–210PubMedGoogle Scholar
  60. 60.
    Frauscher F, Klauser A, Volgger H, Halpern EJ, Pallwein L, Steiner H, Schuster A, Horninger W, Rogatsch H, Bartsch G (2002) Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167:1648–1652CrossRefPubMedGoogle Scholar
  61. 61.
    Halpern EJ, McCue PA, Aksnes AK, Hagen EK, Frauscher F, Gomella LG (2002) Contrast-enhanced US of the prostate with sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology 222:361–366PubMedCrossRefGoogle Scholar
  62. 62.
    Frauscher F, Helweg G, Strasser H, Huelsen A, Janetschek G, Bartsch G, zur Nedden D (1999) Contrast enhanced color Doppler ultrasound in the diagnostic evaluation of prostate cancer. Eur Radiol 9 [Suppl 1]:S18Google Scholar
  63. 63.
    Cochlin DL, Ganatra RH, Griffiths DF (2002) Elastography in the detection of prostatic cancer. Clin Radiol 57:1014–1020CrossRefPubMedGoogle Scholar
  64. 64.
    Sonnad SS, Langlotz CP, Schwartz JS (2001) Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change. Acad Radiol 8:149–157CrossRefPubMedGoogle Scholar
  65. 65.
    Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302PubMedGoogle Scholar
  66. 66.
    Perotti M, Han K-R, Epstein RE, Kennedy EC, Rabbani F, Badani K et al (1999) Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol 162:1314–1317CrossRefPubMedGoogle Scholar
  67. 67.
    Yuen JSP, Thng CH, Tan PH, Khin LW, Phee SJL, Xiao D et al (2004) Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 171:1482–1486CrossRefPubMedGoogle Scholar
  68. 68.
    Rouviere O, Raudrant A, Ecochard R, Colin-Pangaud C, Pasquiou C, Bouvier R, Marechal JM, Lyonnet D (2003) Characterisation of time-enhancement curves of benign and malignant prostate issue at dynamic MR imaging. Eur Radiol 13:931–942PubMedGoogle Scholar
  69. 69.
    Kim H-W, Buckley DL, Peterson DM, Duensing GR, Caserta J, Fitzsimmons J, Blackband SJ (2003) In vivo prostatic magnetic resonance imaging and magnetic resonance spectroscopy at 3 tesla using a transceive pelvic phased array coil. Invest Radiol 38:443–451CrossRefPubMedGoogle Scholar
  70. 70.
    Sosna J, Pedrosa I, Dewolf WC, Mahallati H, Lenkinsi RE, Rofsky NM (2004) MR imaging of the prostate at 3 tesla. Acad Radiol 11:857–862PubMedCrossRefGoogle Scholar
  71. 71.
    Fûtterer JJ, Schenen TWJ, Huisman HJ, Klomp DW, van Dorsten FA, Hulsbergen-van de Kaa CA, Witjes JA, Heerschap A, Barentsz JO (2004) Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1-H-spectroscopic imaging of the prostate. Invest Radiol 39:671–680PubMedCrossRefGoogle Scholar
  72. 72.
    Fûtterer JJ, Heijmink SWTPJ, Scheenen TWJ, Jager GJ, Hulsbergen-van de Kaa CA, Witjes JA, Heerschap A, Barentsz JO (2006) Prostate cancer: local staging at 3-T endorectal MR imaging. Radiology 238:184–191PubMedCrossRefGoogle Scholar
  73. 73.
    Keetch DW, Catalona WJ, Smith DS (1994) Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151:1571–1574PubMedGoogle Scholar
  74. 74.
    Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M (2000) Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1:051 men. J Urol 163:1144–1148CrossRefPubMedGoogle Scholar
  75. 75.
    Djavan B, Fong YK, Ravery V, Remzi M, Horninger W, Susani M, Kreuzer S, Boccon-Gibod L, Bartsch G, Marberger M (2005) Are repeat biopsies required in men with PSA levels < or=4 ng/ml? A multi-institutional prospective European study. Eur Urol 47:38–44CrossRefPubMedGoogle Scholar
  76. 76.
    Wasserman NF, Kapoor DA, Hildebrandt WC, Zhang G, Born KM, Eppel SM, Reddy PK (1992) Transrectal US in evaluation of patients after radical prostatectomy. II. Transrectal US and biopsy findings in the presence of residual and early recurrent prostatic cancer. Radiology 185:367–372PubMedGoogle Scholar
  77. 77.
    Anagnostou T, Doumas K, Remzi M, Djavan B (2004) Postradical prostatectomy TRUS-guided anastomotic biopsy. Where do we stand today? Prostate Cancer Prostatic Dis 7:302–310PubMedCrossRefGoogle Scholar
  78. 78.
    Rogatsch H, Mairinger T, Horninger W, Gschwendtner A, Bartsch G, Mikuz G (2000) Optimized preembedding method improves the histologic yield of prostatic core needle biopsies. Prostate 42:124–129CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.Department of RadiologyRoyal Gwent HospitalNewportUK

Personalised recommendations